Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

37.60 -0.23 (-0.61%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,234,663
Open 38.04
Bid (Size) 37.60 (1)
Ask (Size) 37.85 (38)
Prev. Close 37.83
Today's Range 37.56 - 38.44
52wk Range 36.17 - 54.93
Shares Outstanding 5,606,688,356
Dividend Yield 4.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income
The risk of a dividend cut is minimal, and the yield of this stock is favorable. 
Via The Motley Fool
MarketBeat Week in Review – 5/22 - 5/26
The debt ceiling standoff and inflation continue to fight for investors’ attention as we head into what is historically a quieter period for the markets 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy Interest Rates

Performance

YTD
-26.65%
-26.65%
1 Month
-3.32%
-3.32%
3 Month
-7.80%
-7.80%
6 Month
-24.15%
-24.15%
1 Year
-29.11%
-29.11%

More News

Read More
3 No-Brainer Stocks to Buy for Under $100 Right Now
Via The Motley Fool
Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected
Via Investor's Business Daily
Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex
Via SBWire
Exposures Climate
FDA Nods to Pfizer's Paxlovid for COVID-19: A Potential $8 Billion Lifesaver in 2023
Via Benzinga
Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today
Via Benzinga
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
Via FinancialNewsMedia
Can Pfizer Stock Double Your Money in 3 Years?
Via The Motley Fool
Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases
Via Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
Via Benzinga
Why Pfizer Stock Slipped by 2% Today
Via The Motley Fool
Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall
Via Benzinga
Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual Meeting
From Pfizer Inc.
Via Business Wire
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
Via Benzinga
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
Via The Motley Fool
Most Active Equity Options For Midday - Thursday, May 25
Via Talk Markets
7 Top Stock Tips for June 2023
Via InvestorPlace
Pfizer’s PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19
From Pfizer Inc.
Via Business Wire
Pfizer Has the Prescription for Higher Share Prices
Via MarketBeat
Topics Derivatives Intellectual Property
Exposures Derivatives Intellectual Property
Zura Bio's Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside
Via Benzinga
GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results
Via Benzinga
Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M
Via Benzinga
Why Novavax, Pfizer And BioNTech Shares Are Rising Today
Via Benzinga
Worried About a Recession? 2 Safe Stocks to Buy Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.